Analyst Ratings for ORIC Pharmaceuticals (ORIC)
ORIC Rating Summary
ORIC Price Target Summary
- Highest: $25.00 (H.C. Wainwright)
- Lowest: $14.00 (Stifel)
- Average: $20.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.00 (+135.6%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Avg. $ Target:
$20.00 (+135.6%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2026 | Stifel | Laura Prendergast | New Coverage | Buy (N/A) |
14.00 (N/A) |
7.54 (8.49) |
12.6% | Details |
| 5/15/2026 | Goldman Sachs | Corinne Johnson | Upgrade | Buy (Early-Stage Biotech) |
15.00 (N/A) |
8.34 (8.49) |
1.8% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
